Improving Management of Acute HTN in Patients With Stroke

Slides:

Advertisements

Similar presentations

BLOOD PRESSURE MANAGEMENT IN ACUTE STROKE

Advertisements

Endovascular treatment for Small Core and Anterior circulation Proximal occlusion with Emphasis on minimizing CT to recanalization times Michael D. Hill.

Preventing Strokes One at a Time Acute Interventions and Management 2009.

Blood Pressure Reduction Among Acute Stroke Patients A Randomized Controlled Clinical Trial Jiang He, Yonghong Zhang, Tan Xu, Weijun Tong, Shaoyan Zhang,

Edward P. Sloan, MD, MPH, FACEP Emergency Department Patient Hypertensive Emergencies: Published Guidelines, Articles, & Their Findings.

2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College.

10 Points to Remember on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in AdultsTreatment of Blood Cholesterol to Reduce.

Aim To determine the effects of a Coversyl- based blood pressure lowering regimen on the risk of recurrent stroke among patients with a history of stroke.

Edward C. Jauch, MD, MS FACEP 1 Research Horizons in the Acute Management of ICH.

Thrombolysis for acute ischaemic stroke Clinical

VBWG OASIS-6 The Sixth Organization to Assess Strategies in Acute Ischemic Syndromes trial.

Antithrombotic Therapy in Peripheral Artery Disease Copyright: American College of Chest Physicians 2012 © Antithrombotic Therapy and Prevention.

Date of download: 5/31/2016 Copyright © The American College of Cardiology. All rights reserved. From: Mechanical Thrombectomy for Acute Ischemic Stroke:

ORAL ANTIHYPERTENSIVE THERAPY FOR SEVERE HYPERTENSION IN PREGNANCY AND POSTPARTUM: A SYSTEMATIC REVIEW Tabassum FirozLaura Magee Karen MacDonellBeth Payne.

The impact of hyperacute blood pressure lowering on the early clinical outcome following intracerebral hemorrhage Ryo Itabashia, Kazunori Toyodaa,b, Masahiro.

Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Comprehensive Meta-Analysis of Safety and Efficacy.

Hypertension In The Stroke Patient

Anticoagulation after peripheral Vascular Intervention

Thrombectomy in Acute Stroke

Antithrombotic Therapy in Peripheral Artery Disease

Pseudomonas Infection in Cystic Fibrosis

Learning Objectives. Learning Objectives Variable Response to Clopidogrel.

Oral Anticoagulants and Reversal Agents

Acute Hypertension Management Optimizing Door-to-Needle Time in Ischemic Stroke.

RESISTANT HYPERTENSION OR POOR PATIENT ADHERENCE? TIPS TO GAIN CONTROL

Starting Strong: Initial Evaluation of the Patient With HCV

Traditional parenteral antihypertensive treatment

Acute Heart Failure.

Advanced NSCLC Without Actionable Mutations

Performance Improvement: Emergency Management in Acute Cerebrovascular Patients Current US Guidelines Lisa A. Shultz, MD Medical Director, Lourdes Stroke.

The Clinical Enigma of Cardiogenic Shock

The Changing Therapeutic Landscape of CINV

At The Cutting Edge of Developments in the Management of Hyperkalemia

Newer parenteral antihypertensive treatment

HYPERTENSIVE CRISES Mini-Lecture.

Managing Complex Hypertension: What Every Physician Should Know

Advances in Dyslipidemia: What Have We Learned From ACC 2017

How to Achieve Aggressive BP Goals in Difficult-to-Treat Patients

Natural History of Atherothrombosis Finding the Right Risk-Benefit Balance.

Management of perioperative hypertension

Managing Hard-To-Treat Hypertension: What Every Physician Should Know

Program Goal. Program Goal Current Stroke Guidelines: AHA/ASA.

Strategies to Improve Adherence and Persistence in the Treatment of Hypertension.

HYPERTENSIVE CRISES.

Hypertension Guidelines

Antiplatelet Therapy and Secondary Prevention

Blood pressure control: dependence on adherence

Panelists. Secondary Prevention of Acute Ischemic Stroke: Can We Improve Outcomes?

Introduction. A Reality Check on BP Goals and Optimizing Patient Adherence to Treatment.

A Better Solution For Cancer Patients With VTE?

Reversal Strategies for VKA: Truths and Misconceptions

Program Goals Overview Glatiramer Acetate 3 Times a Week.

Modified Rankin score 0-2

Advancing the Treatment of IBD With Biologics

Multidisciplinary Management of Hyperkalemia:

The Evolving Treatment Landscape in Atopic Dermatitis

Novel Insulin/GLP-1 Combinations: Of Interest to the Primary Care Physician?

WHAT’S NEW WITH THE TREATMENTS FOR HIGH-RISK DYSLIPIDEMIA?

The Adherence Challenge in Schizophrenia Roles of Current and Emerging Therapies.

Tackling CV Risk in Type 2 Diabetes -- Gaps Between Guidelines and Clinical Practice?

Background. Current Perspectives on the Management of Iron Deficiency in Chronic Heart Failure.

Assessing the Burden of Hyperkalemia

Update from education committee

Optimizing Outcomes for Patients With Systemic Lupus Erythematosus: Key Considerations.

Assessing the Burden of Hyperkalemia

Championing Evidence-Based Care in Patients With Acute Low Back Pain

Dr: Hamed Al-Ghamdi CONSULTANT VASCULAR SURGERY

Cardiovascular Epidemiology and Epidemiological Modelling

Selective Immunomodulation in MS

Presentation transcript:

Improving Management of Acute HTN in Patients With Stroke

Case: ED Presentation

2018 AHA/ASA Guidelines For Early Management of Patients With Acute Ischemic Stroke

AIS Management Initial Assessment

Case Further Details

Prevalence of Elevated BP Across Stroke Subtypes

Factors Contributing to HTN in Stroke

Benefits of Controlling HTN in Stroke

BP Control

2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ ASPC/NMA/PCNA Guidelines

VELOCITY Clevidipine for Treatment of Acute Severe HTN

BP Excursions and Stroke Outcome

Treatment Options For Arterial HTN in Patients With AIS Eligible For Acute Reperfusion Therapy

Variable BP Response of IV Labetalol and Nicardipine

Pharmacokinetic Profile of IV Antihypertensive Agents for AIS

ENCHANTED Intensive vs Guideline-Recommended BP Lowering in Patients Treated With Thrombolysis For AIS

ENCHANTED Primary and Safety Outcomes

Antihypertensive Agents Different Pharmacology, Different Effects

Hemodynamic Phenotypes of Suspected Stroke Patients in the ED

Case Continued: Antihypertensive Treatment

Efficacy of Antihypertensive Agents in AIS

AIS Management Hemodynamic Management During Revascularization And Post-Intervention Phases

CATIS Effect of Immediate BP Reduction in Patients With AIS Not Treated With Thrombolytic or Endovascular Therapy

HTN in Patients with AIS Not Treated With Thrombolytic or Endovascular Therapy

No Overall Substantial Change In Cerebral Blood Flow With Rapid Reduction of Severely Elevated BP in ED

Cerebral Autoregulation in Health, Chronic HTN, And Acute Ischemia

Therapeutic Changes In BP And Outcomes in Acute Stroke Metaregression Analysis

Summary General Stroke Care

Summary Patients With AIS And HTN

Abbreviations

Abbreviations (cont)